Related Experiment Video
Updated: Aug 10, 2026

15:25
Examination of the Telomere G-overhang Structure in Trypanosoma brucei
Published on: January 26, 2011
Developments in the differentiation of Trypanosoma brucei
1School of Biological Sciences, University of Manchester, Oxford Road, Manchester, UK M13 9PT. keith.matthews@man.ac.uk
Parasitology Today (Personal Ed.)
|May 11, 1999
Summary
African trypanosomes change significantly throughout their life cycle. Recent research offers insights into the regulation of these complex differentiation events, enabling better study of the parasite
Area of Science:
- * Parasitology
- * Molecular Biology
- * Cell Biology
Background:
- * African trypanosomes undergo significant morphological, metabolic, and gene expression changes during their life cycle.
- * These life cycle transitions are crucial for parasite survival and infectivity.
- * Understanding these changes is key to developing effective treatments.
Purpose of the Study:
- * To provide an overview of recent advances in understanding the regulation of African trypanosome differentiation.
- * To highlight the importance of in vitro models for studying these complex events.
- * To synthesize current knowledge on the control mechanisms governing trypanosome life cycle transitions.
Main Methods:
- * Review of recent scientific literature on African trypanosome biology.
- * Analysis of studies focusing on in vitro cultivation and differentiation.
- * Synthesis of findings related to gene expression and metabolic regulation.
Main Results:
- * Significant progress has been made in understanding the regulatory networks controlling trypanosome differentiation.
- * In vitro systems are proving effective for dissecting the molecular mechanisms underlying life cycle changes.
- * Key factors influencing cell shape, metabolism, and gene expression patterns have been identified.
Conclusions:
- * The regulation of African trypanosome differentiation is a complex, multi-faceted process.
- * Continued research using advanced in vitro models will further elucidate these regulatory mechanisms.
- * A deeper understanding holds promise for novel therapeutic strategies against trypanosomiasis.
Related Concept Videos
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

